Analysts’ Upgrades for March 11th (ABM, AJG, APYX, CRWD, CTAS, CX, ISRG, NIO, NKE, NVS)

Analysts’ upgrades for Wednesday, March 11th:

ABM Industries (NYSE:ABM) was upgraded by analysts at Maxim Group from a hold rating to a buy rating. Maxim Group currently has $50.00 target price on the stock.

Arthur J. Gallagher & Co. (NYSE:AJG) was upgraded by analysts at Barclays PLC from an underweight rating to an overweight rating. They currently have $262.00 price target on the stock, up from their previous price target of $247.00.

Apyx Medical (NASDAQ:APYX) was upgraded by analysts at BTIG Research from a neutral rating to a buy rating. The firm currently has $6.00 target price on the stock.

CrowdStrike (NASDAQ:CRWD) was upgraded by analysts at DZ Bank AG from a sell rating to a buy rating. DZ Bank AG currently has $490.00 target price on the stock.

Cintas (NASDAQ:CTAS) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating. The firm currently has $250.00 price target on the stock.

Cemex (NYSE:CX) was upgraded by analysts at Scotiabank from a sector perform rating to a sector outperform rating. The firm currently has $13.90 target price on the stock, up from their previous target price of $13.50.

Intuitive Surgical (NASDAQ:ISRG) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. They currently have $590.00 target price on the stock.

NIO (NYSE:NIO) was upgraded by analysts at Nomura from a neutral rating to a buy rating. The firm currently has $6.60 target price on the stock.

NIKE (NYSE:NKE) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. Barclays PLC currently has $73.00 target price on the stock, up from their previous target price of $64.00.

Novartis (NYSE:NVS) was upgraded by analysts at Argus from a hold rating to a buy rating. The firm currently has $180.00 target price on the stock.

Oracle (NYSE:ORCL) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $210.00 price target on the stock, down from their previous price target of $230.00.

uniQure (NASDAQ:QURE) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. Mizuho currently has $35.00 target price on the stock, up from their previous target price of $12.00.

Rentokil Initial (NYSE:RTO) was upgraded by analysts at Rothschild & Co Redburn from a sell rating to a neutral rating.

J. M. Smucker (NYSE:SJM) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating. They currently have $145.00 price target on the stock, up from their previous price target of $121.00.

Vera Therapeutics (NASDAQ:VERA) was upgraded by analysts at Wolfe Research from a peer perform rating to an outperform rating. Wolfe Research currently has $88.00 target price on the stock.

VTEX (NYSE:VTEX) was upgraded by analysts at Brean Capital from a hold rating to a buy rating. They currently have $5.00 target price on the stock.

Willis Towers Watson Public (NASDAQ:WTW) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. Barclays PLC currently has $341.00 price target on the stock, up from their previous price target of $318.00.